These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4844516)

  • 41. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Update on mechanical methods of postcoital contraception. Pt. 2].
    Manganelli F; Tomei F; Bergamini V
    Ginecol Clin; 1987; 8(3):189-90. PubMed ID: 12342486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The intrauterine active disposition in the dysfunctional uterine bleeding: its action on miometrium, endometrium and vaginal epithelium].
    Ruiz-velasco V; Martinez Manatau J; Illanes Amurrio S; Romero Salinas G; Maqueo Topete M; Conde De Varges BI
    J Bras Ginecol; 1974 Oct; 78(4):417-31. PubMed ID: 12278214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of T Cu 200 and Progestasert IUDs.
    Lavin P; Bravo C; Waszak C
    Contracept Deliv Syst; 1983 Apr; 4(2):143-7. PubMed ID: 12338635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A new intrauterine device with progesterone for control of reproduction].
    Leone U; Di Girolamo V
    Minerva Ginecol; 1981 Sep; 33(9):805-9. PubMed ID: 7322425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The IUD: dispelling the myths and assessing the potential.
    Mishell Dr ; Sulak PJ
    Dialogues Contracept; 1997; 5(2):1-4. PubMed ID: 12292543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A critical ('stress') evaluation of the combined ML Copper 250-short IUD in nulliparous women.
    Goldstuck ND
    Contracept Deliv Syst; 1981 Oct; 2(4):287-93. PubMed ID: 12336989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lactation pattern in Egyptian women using the Progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Serour G; Hefnawi F
    Contracept Deliv Syst; 1982 Jan; 3(1):53-60. PubMed ID: 12264128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Demographic analysis of post-abortive and interval-administered hormonal contraceptive methods.
    Ertopçu K; Inal MM; Ozelmas I
    Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):1-5. PubMed ID: 16036290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Postplacental application of 5 different types of intrauterine devices].
    Reynoso L; Arevalo N; Lara R; Aznar R
    Ginecol Obstet Mex; 1982 May; 50(301):107-10. PubMed ID: 7182224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical evaluation in vivo and in vitro of cervical mucus in IUD users: differences between women wearing copper and progesterone releasing IUDs.
    Scarselli G; Noci I; Chelo E; Tantini C; Livi C
    Acta Eur Fertil; 1983; 14(4):279-82. PubMed ID: 6689512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The intrauterine device (IUD): are there still contraindications? A study of 300 Gyne-T 380 users (1987-1992)].
    Faguer C
    Contracept Fertil Sex (Paris); 1993 Jan; 21(1):23-6. PubMed ID: 12289991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medicated intrauterine devices: development considerations and clinical uses.
    Chien YW
    J Parenter Drug Assoc; 1980; 34(4):295-323. PubMed ID: 6902777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Intrauterine contraception].
    Tauber PF
    Gynakologe; 1984 Sep; 17(3):185-93. PubMed ID: 6489841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intrauterine devices (IUDs) and their complications (clinical evaluation of 2013 women with IUD in-situ).
    Ayhan A; Ozalp S; Aslan A
    Acta Reprod Turc; 1982 Oct; 4(2):34-8. PubMed ID: 12267258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Apr; 16(4 Suppl):1-8. PubMed ID: 12342078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post coital contraception.
    Haspels AA; Van Santen MR
    J Gynaecol Endocrinol; 1986; 2(1-2):17-24. PubMed ID: 12269214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intrauterine release of progesterone. II. Modification of macromolecular synthesis of endometrium.
    Hernandez O; Ballesteros LM; Aznar R; Delgado NM; Rosado A
    Contracept Deliv Syst; 1981 Oct; 2(4):319-25. PubMed ID: 12336993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors determining the choice of contraceptive methods at the Family Planning Clinic, University College Hospital, Ibadan, Nigeria.
    Konje JC; Oladini F; Otolorin EO; Ladipo OO
    Br J Fam Plann; 1998 Oct; 24(3):107-10. PubMed ID: 9855717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Special requirements for hormone releasing intrauterine devices.
    Zaffaroni A
    Acta Endocrinol Suppl (Copenh); 1974; 185():423-34. PubMed ID: 4593798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.